Breaking News Instant updates and real-time market news.

EDU

New Oriental Education

$2.18 /

-0.025 (-1.14%)

13:34
11/29/21
11/29
13:34
11/29/21
13:34

New Oriental Education options imply 4.5% move in share price post-earnings

Pre-earnings options volume in New Oriental Education is normal with calls leading puts 8:3. Implied volatility suggests the market is anticipating a move near 4.5%, or 10c, after results are released. Median move over the past eight quarters is 4.1%.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Roche's Genentech announces FDA approval of Vabysmo » 18:48
01/28/22
01/28
18:48
01/28/22
18:48
RHHBY

Roche

$48.31 /

+0.61 (+1.28%)

Genentech, a member of…

Genentech, a member of the Roche Group, announced that the U.S. FDA has approved Vabysmo for the treatment of wet, or neovascular, age-related macular degeneration and diabetic macular edema. Wet AMD and DME are two leading causes of vision loss among U.S. adults. Vabysmo targets and inhibits two disease pathways linked to a number of vision-threatening retinal conditions by neutralizing angiopoietin-2 and vascular endothelial growth factor-A. Vabysmo is the first and only FDA-approved injectable eye medicine for wet AMD and DME that improves and maintains vision with treatments from one to four months apart in the first year following four initial monthly doses, based on evaluation of the patient's anatomy and vision outcomes. Standard of care for wet AMD and DME typically requires eye injections every one to two months.

ShowHide Related Items >><<
RHHBY Roche
$48.31 /

+0.61 (+1.28%)

RHHBY Roche
$48.31 /

+0.61 (+1.28%)

01/14/22 BofA
Biogen price target lowered to $245 from $275 at BofA
01/04/22 JPMorgan
Roche price target raised to CHF 390 from CHF 360 at JPMorgan
12/22/21 Citi
Roche resumed with a Buy at Citi
12/13/21 Credit Suisse
Roche price target raised to CHF 370 from CHF 350 at Credit Suisse
RHHBY Roche
$48.31 /

+0.61 (+1.28%)

RHHBY Roche
$48.31 /

+0.61 (+1.28%)

RHHBY Roche
$48.31 /

+0.61 (+1.28%)

Hot Stocks
Boot Barn CEO: Plenty of opportunities to grow the business » 18:28
01/28/22
01/28
18:28
01/28/22
18:28
BOOT

Boot Barn

$85.64 /

-9.45 (-9.94%)

In an interview on…

In an interview on CNBC's Mad Money, Jim Conroy said Boot Barn continues to be a fast growing company and the valuation will take care of itself over time. He is convinced the company can at least double or triple its store count. New stores in new markets are exceeding expectations, he added. Conroy is seeing a fair amount of same store sales from legacy clients, and noted that the Western customer is "hardly tapped out." Recently, the company has experienced growth in the oil patch, he said.

ShowHide Related Items >><<
BOOT Boot Barn
$85.64 /

-9.45 (-9.94%)

BOOT Boot Barn
$85.64 /

-9.45 (-9.94%)

01/28/22 Baird
Boot Barn price target lowered to $130 from $145 at Baird
01/18/22 Seaport Global
Seaport lists Nike, Foot Locker among Buys in Apparel/Footwear sector
01/18/22 Seaport Global
Boot Barn initiated with a Neutral at Seaport Global
01/10/22
Boot Barn participates in a conference call with Benchmark
BOOT Boot Barn
$85.64 /

-9.45 (-9.94%)

BOOT Boot Barn
$85.64 /

-9.45 (-9.94%)

BOOT Boot Barn
$85.64 /

-9.45 (-9.94%)

Syndicate
U.S. Gold files $100M mixed securities shelf  17:28
01/28/22
01/28
17:28
01/28/22
17:28
USAU

U.S. Gold

$6.08 /

-0.185 (-2.95%)

 
ShowHide Related Items >><<
USAU U.S. Gold
$6.08 /

-0.185 (-2.95%)

USAU U.S. Gold
$6.08 /

-0.185 (-2.95%)

12/02/21 Alliance Global Partners
U.S. Gold price target raised to $25 from $20 at Alliance Global Partners
04/08/21 Alliance Global Partners
U.S. Gold price target lowered to $20 from $25 at Alliance Global Partners
Syndicate
Ageagle Aerial Systems files to sell 1.93M shares of common stock for holders  17:28
01/28/22
01/28
17:28
01/28/22
17:28
UAVS

Ageagle Aerial Systems

$1.10 /

+0.05 (+4.78%)

 
ShowHide Related Items >><<
UAVS Ageagle Aerial Systems
$1.10 /

+0.05 (+4.78%)

UAVS Ageagle Aerial Systems
$1.10 /

+0.05 (+4.78%)

UAVS Ageagle Aerial Systems
$1.10 /

+0.05 (+4.78%)

Syndicate
Revelation Biosciences files to sell 5.17M shares of common stock for holders  17:12
01/28/22
01/28
17:12
01/28/22
17:12
REVB

Revelation Biosciences

$2.41 /

-0.26 (-9.74%)

 
ShowHide Related Items >><<
REVB Revelation Biosciences
$2.41 /

-0.26 (-9.74%)

Hot Stocks
General Dynamics awarded $171M Army contract » 17:11
01/28/22
01/28
17:11
01/28/22
17:11
GD

General Dynamics

$212.94 /

+4.04 (+1.93%)

General Dynamics was…

General Dynamics was awarded a $171M hybrid contract for support services for biomedical research application, evaluation. Bids were solicited via the internet with three received. Work locations and funding will be determined with each order, with an estimated completion date of January 27, 2027. U.S. Army Medical Research Acquisition Activity is the contracting activity.

ShowHide Related Items >><<
GD General Dynamics
$212.94 /

+4.04 (+1.93%)

GD General Dynamics
$212.94 /

+4.04 (+1.93%)

01/28/22 Wolfe Research
General Dynamics upgraded to Peer Perform from Underperform at Wolfe Research
01/10/22 Wells Fargo
General Dynamics price target raised to $235 from $230 at Wells Fargo
12/14/21 UBS
General Dynamics upgraded to Buy at UBS with 'positive bias' for FY22
12/14/21 UBS
General Dynamics upgraded to Buy from Neutral at UBS
GD General Dynamics
$212.94 /

+4.04 (+1.93%)

GD General Dynamics
$212.94 /

+4.04 (+1.93%)

Syndicate
Neptune Wellness files $50M mixed securities shelf  17:10
01/28/22
01/28
17:10
01/28/22
17:10
NEPT

Neptune Wellness

/

+

 
ShowHide Related Items >><<
NEPT Neptune Wellness
/

+

NEPT Neptune Wellness
/

+

11/17/21 Desjardins
Neptune Wellness price target lowered to C$0.75 from C$1.00 at Desjardins
08/16/21 Desjardins
Neptune Wellness price target lowered to C$1 from C$1.10 at Desjardins
07/20/21 Alliance Global Partners
Neptune Wellness price target lowered to C$1.50 from C$4
07/19/21
Fly Intel: Top five analyst downgrades
Initiation
Cyxtera Technologies initiated with an Outperform at William Blair » 17:07
01/28/22
01/28
17:07
01/28/22
17:07
CYXT

Cyxtera Technologies

$11.45 /

+0.535 (+4.90%)

William Blair analyst…

William Blair analyst James Breen earlier today initiated coverage of Cyxtera Technologies with an Outperform rating and no price target. The analyst expects the company's revenue to accelerate from 2% annual growth to the mid- to high single digits as it fills existing capacity and increases occupancy. As the business scales, there is high revenue flow-through from increased occupancy and interconnection growth, which should result in operating leverage, said Breen in a note to investors. He calls Cyxtera a global data center with scale.

ShowHide Related Items >><<
CYXT Cyxtera Technologies
$11.45 /

+0.535 (+4.90%)

CYXT Cyxtera Technologies
$11.45 /

+0.535 (+4.90%)

01/06/22 Cowen
Cyxtera Technologies initiated with an Outperform at Cowen
01/03/22 UBS
Cyxtera Technologies initiated with a Neutral at UBS
12/16/21 RBC Capital
Cyxtera Technologies initiated with an Outperform at RBC Capital
12/10/21 Truist
Cyxtera Technologies initiated with a Buy at Truist
CYXT Cyxtera Technologies
$11.45 /

+0.535 (+4.90%)

CYXT Cyxtera Technologies
$11.45 /

+0.535 (+4.90%)

Hot Stocks
MMTEC receives noncompliance notification from Nasdaq » 17:05
01/28/22
01/28
17:05
01/28/22
17:05
MTC

MMTEC

/

+

MMTEC announced that the…

MMTEC announced that the company received a notification letter from the listings qualifications department of Nasdaq regarding a failure to meet Nasdaq's minimum bid price requirements. The notification letter informed the company that the minimum closing bid price per share for its common stock was below $1.00 for a period of 30 consecutive business days and that the company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550. This press release is issued pursuant to Nasdaq Listing Rule 5810, which requires prompt disclosure of receipt of a deficiency notification. The notification letter has no immediate effect on the listing or trading of the company's common stock on Nasdaq.

ShowHide Related Items >><<
    Periodicals
    U.S. sees at least 127 known cases of omicron subvariant, CNBC says » 17:02
    01/28/22
    01/28
    17:02
    01/28/22
    17:02
    SPX

    S&P 500

    /

    +

    , SPY

    SPDR S&P 500 ETF Trust

    $441.92 /

    +10.66 (+2.47%)

    , PFE

    Pfizer

    $54.33 /

    +0.97 (+1.82%)

    , BNTX

    BioNTech

    $162.00 /

    +7.51 (+4.86%)

    , MRNA

    Moderna

    $159.44 /

    +10.82 (+7.28%)

    , JNJ

    Johnson & Johnson

    $171.73 /

    +1.11 (+0.65%)

    At least 127 known cases…

    At least 127 known cases across the U.S. of a new COVID-19 subvariant have emerged recently in nearly half of all U.S. states, CNBC's Spencer Kimball reports. The CDC said that BA.2, a subvariant of omicron, has increased in proportion to the original omicron strain, known as BA.1, in some countries, though it is currently circulating at a low level in the U.S., the author says. The subvariant is 1.5x more transmissible than the BA.1 strain, though it does not appear to further reduce the effectiveness of vaccines against symptomatic infection, nor is there any current evidence that BA.2 is more sever than BA.1, the author notes, citing the U.K. Health Security Agency. Makers of COVID-19 vaccines approved for use in the U.S. include Pfizer (PFE) and BioNTech (BNTX), Moderna (MRNA), and Johnson & Johnson (JNJ). Reference Link

    ShowHide Related Items >><<
    SPY SPDR S&P 500 ETF Trust
    $441.92 /

    +10.66 (+2.47%)

    SPX S&P 500
    /

    +

    PFE Pfizer
    $54.33 /

    +0.97 (+1.82%)

    MRNA Moderna
    $159.44 /

    +10.82 (+7.28%)

    JNJ Johnson & Johnson
    $171.73 /

    +1.11 (+0.65%)

    BNTX BioNTech
    $162.00 /

    +7.51 (+4.86%)

    SPX S&P 500
    /

    +

    01/24/22 JPMorgan
    JPMorgan macro strategist says market correction in final stages
    11/26/21 Morgan Stanley
    Covid variant mutations may reduce vaccine effectiveness, says Morgan Stanley
    11/26/21 Credit Suisse
    Concerns over new Covid variant 'understandable,' says Credit Suisse
    11/22/21 BTIG
    In picking Powell, Biden went with 'safest choice,' says BTIG
    SPY SPDR S&P 500 ETF Trust
    $441.92 /

    +10.66 (+2.47%)

    PFE Pfizer
    $54.33 /

    +0.97 (+1.82%)

    01/28/22 JPMorgan
    Pfizer price target raised to $57 from $53 at JPMorgan
    01/25/22 Piper Sandler
    Arcturus reported 'outstanding' omicron vaccine data, says Piper Sandler
    01/25/22 JMP Securities
    eFfector Therapeutics price target lowered to $8 from $33 at JMP Securities
    01/24/22 Barrington
    Barrington downgrades Opko Health on somatrogon regulatory setback
    BNTX BioNTech
    $162.00 /

    +7.51 (+4.86%)

    01/19/22 Credit Suisse
    Genmab price target lowered to DKK 2,600 from DKK 2,850 at Credit Suisse
    12/22/21 Kempen
    BioNTech upgraded to Buy from Neutral at Kempen
    12/21/21 H.C. Wainwright
    BioNTech price target raised to $366 from $360 at H.C. Wainwright
    12/16/21 Morgan Stanley
    BioNTech initiated with an Equal Weight at Morgan Stanley
    MRNA Moderna
    $159.44 /

    +10.82 (+7.28%)

    01/26/22 Deutsche Bank
    Moderna upgraded to Hold from Sell at Deutsche Bank
    01/21/22 BofA
    Moderna upgraded to Neutral at BofA on more favorable risk-reward
    01/21/22 UBS
    Moderna initiated with a Neutral at UBS
    JNJ Johnson & Johnson
    $171.73 /

    +1.11 (+0.65%)

    01/26/22 Raymond James
    Johnson & Johnson price target raised to $185 from $178 at Raymond James
    01/25/22 Citi
    Johnson & Johnson quarter reflected 'resilience,' says Citi
    12/29/21 Credit Suisse
    Credit Suisse reiterates Outperform on J&J as trends point to pharma upside
    12/17/21
    Fly Intel: Top five analyst initiations
    PFE Pfizer
    $54.33 /

    +0.97 (+1.82%)

    MRNA Moderna
    $159.44 /

    +10.82 (+7.28%)

    JNJ Johnson & Johnson
    $171.73 /

    +1.11 (+0.65%)

    BNTX BioNTech
    $162.00 /

    +7.51 (+4.86%)

    SPX S&P 500
    /

    +

    PFE Pfizer
    $54.33 /

    +0.97 (+1.82%)

    MRNA Moderna
    $159.44 /

    +10.82 (+7.28%)

    JNJ Johnson & Johnson
    $171.73 /

    +1.11 (+0.65%)

    BNTX BioNTech
    $162.00 /

    +7.51 (+4.86%)

    SPX S&P 500
    /

    +

    PFE Pfizer
    $54.33 /

    +0.97 (+1.82%)

    MRNA Moderna
    $159.44 /

    +10.82 (+7.28%)

    JNJ Johnson & Johnson
    $171.73 /

    +1.11 (+0.65%)

    BNTX BioNTech
    $162.00 /

    +7.51 (+4.86%)

    SPY SPDR S&P 500 ETF Trust
    $441.92 /

    +10.66 (+2.47%)

    SPX S&P 500
    /

    +

    PFE Pfizer
    $54.33 /

    +0.97 (+1.82%)

    MRNA Moderna
    $159.44 /

    +10.82 (+7.28%)

    JNJ Johnson & Johnson
    $171.73 /

    +1.11 (+0.65%)

    BNTX BioNTech
    $162.00 /

    +7.51 (+4.86%)

    SPY SPDR S&P 500 ETF Trust
    $441.92 /

    +10.66 (+2.47%)

    SPX S&P 500
    /

    +

    Hot Stocks
    SmartFinancial raises quarterly dividend 17% to 7c per share » 17:01
    01/28/22
    01/28
    17:01
    01/28/22
    17:01
    SMBK

    SmartFinancial

    $26.10 /

    -0.39 (-1.47%)

    Payable on February 28 to…

    Payable on February 28 to shareholders of record as of the close of business on February 11.

    ShowHide Related Items >><<
    SMBK SmartFinancial
    $26.10 /

    -0.39 (-1.47%)

    SMBK SmartFinancial
    $26.10 /

    -0.39 (-1.47%)

    01/26/22 Raymond James
    SmartFinancial price target raised to $33 from $30 at Raymond James
    07/21/21 Raymond James
    SmartFinancial price target raised to $30 from $27 at Raymond James
    04/22/21 Raymond James
    SmartFinancial upgraded to Strong Buy from Outperform at Raymond James
    SMBK SmartFinancial
    $26.10 /

    -0.39 (-1.47%)

    Syndicate
    Arcadia Biosciences files to sell 2.75M shares of common stock for holders  16:58
    01/28/22
    01/28
    16:58
    01/28/22
    16:58
    RKDA

    Arcadia Biosciences

    /

    +

     
    ShowHide Related Items >><<
    RKDA Arcadia Biosciences
    /

    +

    RKDA Arcadia Biosciences
    /

    +

    01/03/22 H.C. Wainwright
    Arcadia Biosciences price target lowered to $6 from $7 at H.C. Wainwright
    06/01/21 H.C. Wainwright
    Arcadia Biosciences price target raised to $7 from $6 at H.C. Wainwright
    05/11/21 Lake Street
    Arcadia Biosciences initiated with a Buy at Lake Street
    02/09/21 H.C. Wainwright
    Arcadia Biosciences price target lowered to $6 from $8 at H.C. Wainwright
    RKDA Arcadia Biosciences
    /

    +

    Periodicals
    Google cloud division reorganizes partnerships, sales groups, CNBC says » 16:55
    01/28/22
    01/28
    16:55
    01/28/22
    16:55
    GOOG

    Alphabet

    $2,666.84 /

    +83.78 (+3.24%)

    , GOOGL

    Alphabet Class A

    $2,666.17 /

    +81.3 (+3.15%)

    Google's cloud…

    Google's cloud business is reorganizing once again, shifting around management of its sales and partnerships operations, CNBC's Jennifer Elias reports. Rob Enslin, president of cloud sales at the search giant, announce a number of changes this week, notably that Carolee Gearhart, who has overseen the channel partner business worldwide for Google Cloud Platform and Google Workspace, is leaving to take a position elsewhere, Elias says, citing emails sent to employees in the cloud unit. Kevin Ichhpurani has been named the new head of the channels business, the author notes. Reference Link

    ShowHide Related Items >><<
    GOOG Alphabet
    $2,666.84 /

    +83.78 (+3.24%)

    GOOG Alphabet
    $2,666.84 /

    +83.78 (+3.24%)

    01/19/22 BofA
    Alphabet price target raised to $3,470 from $3,210 at BofA
    01/19/22 Morgan Stanley
    Alphabet price target raised to $3,430 from $3,200 at Morgan Stanley
    01/19/22 Citi
    Citi says other bidders could emerge for Activision Blizzard
    01/13/22 Cowen
    Alphabet price target raised to $3,500 from $3,360 at Cowen
    GOOGL Alphabet Class A
    $2,666.17 /

    +81.3 (+3.15%)

    01/28/22 Credit Suisse
    Alphabet Class A price target lowered to $3,400 from $3,450 at Credit Suisse
    01/24/22 BofA
    Bofa adds two, removes three from best investment ideas list
    GOOG Alphabet
    $2,666.84 /

    +83.78 (+3.24%)

    GOOG Alphabet
    $2,666.84 /

    +83.78 (+3.24%)

    GOOG Alphabet
    $2,666.84 /

    +83.78 (+3.24%)

    GOOGL Alphabet Class A
    $2,666.17 /

    +81.3 (+3.15%)

    Conference/Events
    Wejo management to meet virtually with Piper Sandler » 16:47
    01/28/22
    01/28
    16:47
    01/28/22
    16:47
    WEJO

    Wejo

    $3.71 /

    +0.005 (+0.13%)

    Virtual Meeting to be…

    Virtual Meeting to be held on February 1 hosted by Piper Sandler.

    ShowHide Related Items >><<
    WEJO Wejo
    $3.71 /

    +0.005 (+0.13%)

    WEJO Wejo
    $3.71 /

    +0.005 (+0.13%)

    12/21/21 Wedbush
    Wedbush starts auto industry data analytics play Wejo at Outperform
    12/21/21 Wedbush
    Wejo initiated with an Outperform at Wedbush
    12/15/21 Baird
    Wejo continues progress on foundation build, says Baird
    12/08/21 Baird
    Wejo initiated with an Outperform at Baird
    WEJO Wejo
    $3.71 /

    +0.005 (+0.13%)

    WEJO Wejo
    $3.71 /

    +0.005 (+0.13%)

    Hot Stocks
    Adtran says acceptance threshold met for Adva Optical deal » 16:44
    01/28/22
    01/28
    16:44
    01/28/22
    16:44
    ADTN

    Adtran

    $18.37 /

    +0.66 (+3.73%)

    , ADVOF

    Adva Optical

    $13.41 /

    + (+0.00%)

    Adtran (ADTN) announced…

    Adtran (ADTN) announced that as of the end of the initial acceptance period on January 26, the voluntary public takeover offer by Acorn HoldCo to all shareholders of ADVA Optical Networking SE (ADVOF) has been accepted by more than 60% of all shares of ADVA Optical Networking SE entitled to voting rights existing as of October 31, 2021, thus exceeding the required minimum acceptance threshold. The consummation of the offer remains subject to regulatory approvals.

    ShowHide Related Items >><<
    ADTN Adtran
    $18.37 /

    +0.66 (+3.73%)

    ADTN Adtran
    $18.37 /

    +0.66 (+3.73%)

    01/03/22 Northland
    Adtran named a top pick for 2022 at Northland
    10/22/21 Northland
    Cambium Networks price target lowered to $50 from $64 at Northland
    08/31/21 Northland
    Northland ups Adtran target, calls ADVA combo 'unexpected but attractive'
    08/06/21 Cowen
    Adtran upgraded to Outperform from Market Perform at Cowen
    ADVOF Adva Optical
    $13.41 /

    + (+0.00%)

    ADTN Adtran
    $18.37 /

    +0.66 (+3.73%)

    ADTN Adtran
    $18.37 /

    +0.66 (+3.73%)

    Syndicate
    Xeris Biopharma files $250M mixed securities shelf  16:36
    01/28/22
    01/28
    16:36
    01/28/22
    16:36
    XERS

    Xeris Biopharma

    $2.06 /

    +0.05 (+2.49%)

     
    ShowHide Related Items >><<
    XERS Xeris Biopharma
    $2.06 /

    +0.05 (+2.49%)

    XERS Xeris Biopharma
    $2.06 /

    +0.05 (+2.49%)

    12/31/21 SVB Leerink
    Xeris price target bumped to $8 at SVB Leerink after Recorlev approval
    12/31/21 SVB Leerink
    Xeris Biopharma price target raised to $8 from $6 at SVB Leerink
    12/31/21 H.C. Wainwright
    Xeris Biopharma price target raised to $5.40 from $4.25 at H.C. Wainwright
    12/31/21 Piper Sandler
    Xeris Biopharma sales could top $300M by 2024, says Piper Sandler
    XERS Xeris Biopharma
    $2.06 /

    +0.05 (+2.49%)

    XERS Xeris Biopharma
    $2.06 /

    +0.05 (+2.49%)

    XERS Xeris Biopharma
    $2.06 /

    +0.05 (+2.49%)

    Hot Stocks
    Eros STX Global announces one-for-twenty reverse stock split » 16:35
    01/28/22
    01/28
    16:35
    01/28/22
    16:35
    ESGC

    Eros STX Global

    /

    +

    Eros STX Global announced…

    Eros STX Global announced that its Board of Directors has approved a one-for-twenty reverse split of its issued and outstanding A and B ordinary shares. The Reverse Stock Split will become effective as of 5:00 p.m. Eastern Time on February 7, and the Company's A ordinary shares are expected to begin trading on a post-split basis when the market opens on February 8. The company's A ordinary shares will continue to trade on The New York Stock Exchange under the symbol "ESGC." The new CUSIP number for the A ordinary shares following the Reverse Stock Split will be G3788R105.

    ShowHide Related Items >><<
    ESGC Eros STX Global
    /

    +

    ESGC Eros STX Global
    /

    +

    ESGC Eros STX Global
    /

    +

    Syndicate
    Xeris Biopharma files to sell 15.36M shares of common stock for holders  16:34
    01/28/22
    01/28
    16:34
    01/28/22
    16:34
    XERS

    Xeris Biopharma

    $2.06 /

    +0.05 (+2.49%)

     
    ShowHide Related Items >><<
    XERS Xeris Biopharma
    $2.06 /

    +0.05 (+2.49%)

    XERS Xeris Biopharma
    $2.06 /

    +0.05 (+2.49%)

    12/31/21 SVB Leerink
    Xeris price target bumped to $8 at SVB Leerink after Recorlev approval
    12/31/21 SVB Leerink
    Xeris Biopharma price target raised to $8 from $6 at SVB Leerink
    12/31/21 H.C. Wainwright
    Xeris Biopharma price target raised to $5.40 from $4.25 at H.C. Wainwright
    12/31/21 Piper Sandler
    Xeris Biopharma sales could top $300M by 2024, says Piper Sandler
    XERS Xeris Biopharma
    $2.06 /

    +0.05 (+2.49%)

    XERS Xeris Biopharma
    $2.06 /

    +0.05 (+2.49%)

    XERS Xeris Biopharma
    $2.06 /

    +0.05 (+2.49%)

    Syndicate
    Lexaria Bioscience files $50M mixed securities shelf  16:34
    01/28/22
    01/28
    16:34
    01/28/22
    16:34
    LEXX

    Lexaria Bioscience

    $4.08 /

    -0.07 (-1.69%)

     
    ShowHide Related Items >><<
    LEXX Lexaria Bioscience
    $4.08 /

    -0.07 (-1.69%)

    LEXX Lexaria Bioscience
    $4.08 /

    -0.07 (-1.69%)

    Earnings
    CB Financial Services reports Q4 adjusted EPS 53c, consensus 75c » 16:32
    01/28/22
    01/28
    16:32
    01/28/22
    16:32
    CBFV

    CB Financial Services

    $24.19 /

    + (+0.00%)

    Net interest margin…

    Net interest margin improved quarter over quarter to 2.95% from 2.88% for the three months ended September 30, 2021. NIM was 3.21% for the prior year period. President and CEO John H. Montgomery stated, "As we enter 2022, we are well-positioned for a rising rate environment. We are squarely focused on capturing growth opportunities and are investing in our business in support of that. A key component of our optimization initiative was the reduction of low return uses of capital so that capital could be repurposed for higher growth investment. With that in mind, we expect to bring on a Chief Commercial Banking Officer and a Director of Client Experience and Retail Banking during the first quarter. Set against the backdrop of reduced annual expense levels and rising interest rates, our expectation is for continued growth and expansion of profitability. In addition, we remain committed to CB's shareholders through the payment of dividends and an active share buy-back program."

    ShowHide Related Items >><<
    CBFV CB Financial Services
    $24.19 /

    + (+0.00%)

    Syndicate
    Check-Cap files $200M mixed securities shelf  16:32
    01/28/22
    01/28
    16:32
    01/28/22
    16:32
    CHEK

    Check-Cap

    /

    +

     
    ShowHide Related Items >><<
    CHEK Check-Cap
    /

    +

    CHEK Check-Cap
    /

    +

    03/17/21 Dawson James
    Check-Cap downgraded to Neutral from Buy at Dawson James
    03/16/21 H.C. Wainwright
    Check-Cap price target raised to $4 from $1.50 at H.C. Wainwright
    Options
    Preliminary option volume of 49.0M today » 16:30
    01/28/22
    01/28
    16:30
    01/28/22
    16:30

    Preliminary option volume…

    Preliminary option volume of 49.0M today is 21% above recent average. Calls led puts 25.03M to 24.01M.

    On The Fly
    Wall Street in Fives - Must Read Lists for Friday » 16:25
    01/28/22
    01/28
    16:25
    01/28/22
    16:25
    AAPL

    Apple

    $170.28 /

    +11.13 (+6.99%)

    , CAT

    Caterpillar

    $201.19 /

    -11.09 (-5.22%)

    , BIIB

    Biogen

    $225.22 /

    +6.35 (+2.90%)

    , SSNLF

    Samsung

    $57.75 /

    + (+0.00%)

    , HD

    Home Depot

    $366.45 /

    +9.815 (+2.75%)

    , LLY

    Eli Lilly

    $245.09 /

    +8.3 (+3.51%)

    , TER

    Teradyne

    $112.15 /

    +0.99 (+0.89%)

    , AFRM

    Affirm

    $59.71 /

    +8.73 (+17.12%)

    , LH

    LabCorp

    $270.12 /

    +4.27 (+1.61%)

    , DGX

    Quest Diagnostics

    $134.78 /

    -0.41 (-0.30%)

    , VFC

    VF Corp.

    $62.96 /

    -4.365 (-6.48%)

    , ECVT

    Ecovyst

    $10.35 /

    +0.965 (+10.28%)

    , MMM

    3M

    $163.09 /

    -7.03 (-4.13%)

    , MDLZ

    Mondelez

    $66.42 /

    -1.135 (-1.68%)

    , GOOG

    Alphabet

    $2,666.84 /

    +83.78 (+3.24%)

    , GOOGL

    Alphabet Class A

    $2,666.17 /

    +81.3 (+3.15%)

    , UNCRY

    UniCredit

    $7.69 /

    +0.05 (+0.65%)

    , PODD

    Insulet

    $230.57 /

    +36.16 (+18.60%)

    , FICO

    Fair Isaac

    $493.32 /

    +65.15 (+15.22%)

    , X

    U.S. Steel

    $19.55 /

    +0.96 (+5.16%)

    , TEAM

    Atlassian

    $318.89 /

    +27.54 (+9.45%)

    , KR

    Kroger

    $43.46 /

    -1.94 (-4.27%)

    , BAH

    Booz Allen

    $75.27 /

    -6.74 (-8.22%)

    , WAL

    Western Alliance

    $95.19 /

    -12.19 (-11.35%)

    , CVX

    Chevron

    $130.62 /

    -4.74 (-3.50%)

    , HOOD

    Robinhood

    $12.74 /

    +1.13 (+9.73%)

    , V

    Visa

    $228.06 /

    +21.93 (+10.64%)

    , RHI

    Robert Half

    $110.26 /

    -0.89 (-0.80%)

    , CL

    Colgate-Palmolive

    $83.09 /

    +0.38 (+0.46%)

    Get caught up quickly on…

    ShowHide Related Items >><<
    X U.S. Steel
    $19.55 /

    +0.96 (+5.16%)

    WAL Western Alliance
    $95.19 /

    -12.19 (-11.35%)

    VFC VF Corp.
    $62.96 /

    -4.365 (-6.48%)

    V Visa
    $228.06 /

    +21.93 (+10.64%)

    UNCRY UniCredit
    $7.69 /

    +0.05 (+0.65%)

    TER Teradyne
    $112.15 /

    +0.99 (+0.89%)

    TEAM Atlassian
    $318.89 /

    +27.54 (+9.45%)

    SSNLF Samsung
    $57.75 /

    + (+0.00%)

    RHI Robert Half
    $110.26 /

    -0.89 (-0.80%)

    PODD Insulet
    $230.57 /

    +36.16 (+18.60%)

    MMM 3M
    $163.09 /

    -7.03 (-4.13%)

    MDLZ Mondelez
    $66.42 /

    -1.135 (-1.68%)

    LLY Eli Lilly
    $245.09 /

    +8.3 (+3.51%)

    LH LabCorp
    $270.12 /

    +4.27 (+1.61%)

    KR Kroger
    $43.46 /

    -1.94 (-4.27%)

    HOOD Robinhood
    $12.74 /

    +1.13 (+9.73%)

    HD Home Depot
    $366.45 /

    +9.815 (+2.75%)

    GOOG Alphabet
    $2,666.84 /

    +83.78 (+3.24%)

    FICO Fair Isaac
    $493.32 /

    +65.15 (+15.22%)

    ECVT Ecovyst
    $10.35 /

    +0.965 (+10.28%)

    DGX Quest Diagnostics
    $134.78 /

    -0.41 (-0.30%)

    CVX Chevron
    $130.62 /

    -4.74 (-3.50%)

    CL Colgate-Palmolive
    $83.09 /

    +0.38 (+0.46%)

    CAT Caterpillar
    $201.19 /

    -11.09 (-5.22%)

    BIIB Biogen
    $225.22 /

    +6.35 (+2.90%)

    BAH Booz Allen
    $75.27 /

    -6.74 (-8.22%)

    AFRM Affirm
    $59.71 /

    +8.73 (+17.12%)

    AAPL Apple
    $170.28 /

    +11.13 (+6.99%)

    AAPL Apple
    $170.28 /

    +11.13 (+6.99%)

    01/28/22 New Street
    Apple upgraded to Neutral from Sell at New Street
    01/28/22 Monness Crespi
    Apple price target raised to $199 from $184 at Monness Crespi
    01/28/22 Morgan Stanley
    Apple price target raised to $210 from $200 at Morgan Stanley
    01/28/22 Wedbush
    Apple's December quarter 'Rocky Balboa-like,' says Wedbush
    CAT Caterpillar
    $201.19 /

    -11.09 (-5.22%)

    01/21/22 Baird
    Caterpillar, Manitowoc have positive read from Schlumberger comments, says Baird
    01/13/22 Barclays
    Caterpillar price target raised to $225 from $220 at Barclays
    01/13/22 Citi
    Caterpillar price target raised to $230 from $225 at Citi
    01/12/22 UBS
    Caterpillar price target raised to $250 from $235 at UBS
    BIIB Biogen
    $225.22 /

    +6.35 (+2.90%)

    01/28/22 JPMorgan
    Biogen divestiture bolsters balance sheet, says JPMorgan
    01/20/22 Barclays
    Biogen price target lowered to $244 from $280 at Barclays
    01/14/22 Jefferies
    Biogen remains 'open to all options on the table,' says Jefferies
    01/14/22 BofA
    Biogen price target lowered to $245 from $275 at BofA
    SSNLF Samsung
    $57.75 /

    + (+0.00%)

    12/29/21 Benchmark
    Benchmark says Western Digital getting boost from report of Samsung NAND trouble
    12/29/21 Wells Fargo
    Samsung NAND news positive for Western Digital and Micron, says Wells Fargo
    12/28/21 Roth Capital
    Digital Turbine's value proposition endorsed in Google deal, says Roth Capital
    12/01/21 Needham
    Ambarella price target raised to $225 from $220 at Needham
    HD Home Depot
    $366.45 /

    +9.815 (+2.75%)

    01/12/22 Truist
    Home Depot upgraded to Buy at Truist, sees market share gain potential
    01/12/22 Truist
    Home Depot assumed with a Buy at Truist
    01/06/22 Baird
    Masco may ultimately be helped by pro expansion, says Baird
    01/05/22 Wells Fargo
    Home Depot price target raised to $460 from $420 at Wells Fargo
    LLY Eli Lilly
    $245.09 /

    +8.3 (+3.51%)

    01/21/22 DZ Bank
    Eli Lilly upgraded to Buy from Hold at DZ Bank
    01/12/22 Wells Fargo
    CMS proposed coverage with evidence 'a clear negative,' says Wells Fargo
    01/05/22 Mizuho
    Eli Lilly price target raised to $302 from $272 at Mizuho
    TER Teradyne
    $112.15 /

    +0.99 (+0.89%)

    01/28/22 Evercore ISI
    Teradyne price target lowered to $150, removed from 'Top Picks' list at Evercore
    01/28/22 Susquehanna
    Teradyne price target lowered to $150 from $165 at Susquehanna
    01/28/22 Baird
    Teradyne price target lowered to $142 from $160 at Baird
    01/28/22 Stifel
    Stifel 'not throwing in the towel,' but cuts '2H stock' Teradyne to Hold
    AFRM Affirm
    $59.71 /

    +8.73 (+17.12%)

    01/28/22 DA Davidson
    Affirm upgraded to Buy from Neutral at DA Davidson
    01/25/22 Mizuho
    Mizuho survey shows 'promising start' to Affirm checkout on Amazon
    01/25/22 Mizuho
    Affirm price target lowered to $100 from $140 at Mizuho
    01/24/22 Stephens
    Stephens upgrades 'cheap enough' Affirm to Equal Weight
    LH LabCorp
    $270.12 /

    +4.27 (+1.61%)

    01/28/22 Deutsche Bank
    LabCorp downgraded to Hold at Deutsche Bank on margin concerns
    01/28/22 Deutsche Bank
    Quest Diagnostics downgraded to Hold at Deutsche Bank on margin concerns
    01/28/22 Deutsche Bank
    LabCorp downgraded to Hold from Buy at Deutsche Bank
    01/10/22 Citi
    LabCorp transferred with Buy rating at Citi
    DGX Quest Diagnostics
    $134.78 /

    -0.41 (-0.30%)

    01/28/22 Deutsche Bank
    Quest Diagnostics downgraded to Hold from Buy at Deutsche Bank
    01/19/22 Truist
    Quest Diagnostics price target lowered to $160 from $170 at Truist
    VFC VF Corp.
    $62.96 /

    -4.365 (-6.48%)

    01/28/22 JPMorgan
    VF Corp. cut to Neutral at JPMorgan on combination of macro and micro factors
    01/28/22 JPMorgan
    VF Corp. downgraded to Neutral from Overweight at JPMorgan
    01/28/22 BMO Capital
    VF Corp.'s 'disappointing' gross margin 'hard to ignore,' says BMO Capital
    01/24/22 JPMorgan
    VF Corp. price target lowered to $80 from $90 at JPMorgan
    ECVT Ecovyst
    $10.35 /

    +0.965 (+10.28%)

    11/29/21 Citi
    Ecovyst initiated with a Neutral at Citi
    11/16/21 Deutsche Bank
    Ecovyst price target lowered to $16 from $20 at Deutsche Bank
    08/16/21 BMO Capital
    Ecovyst initiated with an Outperform at BMO Capital
    MMM 3M
    $163.09 /

    -7.03 (-4.13%)

    01/28/22 JPMorgan
    3M combat arms litigation emerging as material liability, says JPMorgan
    01/26/22 Argus
    3M price target lowered to $190 from $225 at Argus
    01/26/22 Wells Fargo
    3M price target raised to $184 from $175 at Wells Fargo
    01/11/22 Bernstein
    Bernstein initiates 3M with a Market Perform, $175 price target
    MDLZ Mondelez
    $66.42 /

    -1.135 (-1.68%)

    01/26/22 Mizuho
    Mondelez initiated with a Buy at Mizuho
    01/20/22 Deutsche Bank
    Mondelez price target raised to $73 from $70 at Deutsche Bank
    01/11/22 Morgan Stanley
    Mondelez price target raised to $73 from $69 at Morgan Stanley
    01/05/22 Piper Sandler
    Mondelez price target raised to $75 from $71 at Piper Sandler
    GOOG Alphabet
    $2,666.84 /

    +83.78 (+3.24%)

    01/19/22 BofA
    Alphabet price target raised to $3,470 from $3,210 at BofA
    01/19/22 Morgan Stanley
    Alphabet price target raised to $3,430 from $3,200 at Morgan Stanley
    01/19/22 Citi
    Citi says other bidders could emerge for Activision Blizzard
    01/13/22 Cowen
    Alphabet price target raised to $3,500 from $3,360 at Cowen
    GOOGL Alphabet Class A
    $2,666.17 /

    +81.3 (+3.15%)

    01/28/22 Credit Suisse
    Alphabet Class A price target lowered to $3,400 from $3,450 at Credit Suisse
    01/24/22 BofA
    Bofa adds two, removes three from best investment ideas list
    UNCRY UniCredit
    $7.69 /

    +0.05 (+0.65%)

    01/21/22 Barclays
    UniCredit price target raised to EUR 15 from EUR 13.80 at Barclays
    12/13/21 UBS
    UniCredit price target raised to EUR 19.50 from EUR 14.70 at UBS
    12/13/21 Credit Suisse
    UniCredit price target raised to EUR 15.10 from EUR 13.80 at Credit Suisse
    12/13/21 Citi
    UniCredit price target raised to EUR 15.70 from EUR 14.10 at Citi
    PODD Insulet
    $230.57 /

    +36.16 (+18.60%)

    01/28/22 Stifel
    Stifel senses 'meaningful patient demand' for Insulet's Omnipod 5
    01/28/22 Piper Sandler
    Insulet approval 'clear positive' after several delays, says Piper Sandler
    01/19/22 Wells Fargo
    Wells Fargo upgrades Tandem Diabetes to Overweight, raises target to $160
    01/03/22 William Blair
    Insulet nearing 'positive growth inflection,' says William Blair
    FICO Fair Isaac
    $493.32 /

    +65.15 (+15.22%)

    01/06/22 Needham
    Fair Isaac price target raised to $590 from $550, named 2022 Top Pick at Needham
    01/04/22 Baird
    Fair Isaac price target raised to $535 from $488 at Baird
    11/08/21 Jefferies
    Jefferies upgrades Fair Isaac to Buy, sees 'two ways to win'
    11/08/21 Jefferies
    Fair Isaac upgraded to Buy from Hold at Jefferies
    X U.S. Steel
    $19.55 /

    +0.96 (+5.16%)

    01/11/22 Wolfe Research
    U.S. Steel downgraded to Underperform from Peer Perform at Wolfe Research
    11/16/21 Wolfe Research
    U.S. Steel initiated with a Peer Perform at Wolfe Research
    11/09/21 Citi
    U.S. Steel price target raised to $30 from $26 at Citi
    10/29/21 Credit Suisse
    U.S. Steel too cheap to ignore, says Credit Suisse
    TEAM Atlassian
    $318.89 /

    +27.54 (+9.45%)

    01/28/22 BMO Capital
    Atlassian price target lowered to $382 from $515 at BMO Capital
    01/28/22 Cowen
    Atlassian price target raised to $330 from $325 at Cowen
    01/28/22 Canaccord
    Atlassian price target lowered to $375 from $500 at Canaccord
    01/28/22 Oppenheimer
    Atlassian price target lowered to $430 from $500 at Oppenheimer
    KR Kroger
    $43.46 /

    -1.94 (-4.27%)

    01/28/22 Citi
    Kroger downgraded to Sell on 2022 risks at Citi
    01/28/22 Citi
    Kroger downgraded to Sell from Neutral at Citi
    01/25/22 Wells Fargo
    Wells Fargo downgrades Kroger to Underweight with $42 price target
    01/25/22 Wells Fargo
    Kroger downgraded to Underweight from Equal Weight at Wells Fargo
    BAH Booz Allen
    $75.27 /

    -6.74 (-8.22%)

    01/24/22 Barclays
    Booz Allen upgraded to Overweight from Equal Weight at Barclays
    01/03/22 Cowen
    Booz Allen price target raised to $109 from $105 at Cowen
    09/16/21 Cowen
    Booz Allen price target raised to $100 from $93 at Cowen
    08/02/21 Truist
    Booz Allen price target raised to $88 from $80 at Truist
    WAL Western Alliance
    $95.19 /

    -12.19 (-11.35%)

    01/03/22 Keefe Bruyette
    Apollo long, Rocket short amid KBW's 13 best ideas for 2022
    10/25/21 Truist
    Western Alliance price target raised to $140 from $114 at Truist
    10/25/21 DA Davidson
    Western Alliance price target raised to $145 from $120 at DA Davidson
    10/24/21 Wells Fargo
    Western Alliance price target raised to $150 from $135 at Wells Fargo
    CVX Chevron
    $130.62 /

    -4.74 (-3.50%)

    01/14/22 Truist
    Chevron price target raised to $167 from $150 at Truist
    01/05/22 Wells Fargo
    Wells Fargo upgrades Chevron to Overweight, raises price target to $140
    01/05/22 Wells Fargo
    Chevron upgraded to Overweight from Equal Weight at Wells Fargo
    11/24/21
    Fly Intel: Top five analyst upgrades
    HOOD Robinhood
    $12.74 /

    +1.13 (+9.73%)

    01/28/22 Barclays
    Robinhood price target lowered to $12 from $42 at Barclays
    01/28/22 Deutsche Bank
    Robinhood price target lowered to $12 from $15 at Deutsche Bank
    01/28/22 JMP Securities
    Robinhood price target lowered to $45 from $58 at JMP Securities
    01/28/22 Piper Sandler
    Robinhood price target lowered to $13 from $17 at Piper Sandler
    V Visa
    $228.06 /

    +21.93 (+10.64%)

    01/28/22 Wedbush
    Visa price target raised to $270 from $240 at Wedbush
    01/28/22 Morgan Stanley
    Visa price target raised to $283 from $280 at Morgan Stanley
    01/28/22 Raymond James
    Visa price target raised to $281 from $265 at Raymond James
    01/28/22 Baird
    Visa price target lowered to $290 from $305 at Baird
    RHI Robert Half
    $110.26 /

    -0.89 (-0.80%)

    01/28/22 Truist
    Robert Half price target raised to $120 from $100 at Truist
    10/25/21 BMO Capital
    Robert Half price target raised to $124 from $118 at BMO Capital
    10/22/21 Baird
    Robert Half price target raised to $133 from $122 at Baird
    07/26/21 BMO Capital
    Robert Half price target raised to $106 from $100 at BMO Capital
    CL Colgate-Palmolive
    $83.09 /

    +0.38 (+0.46%)

    12/16/21 Redburn
    Colgate-Palmolive initiated with a Neutral at Redburn
    11/02/21 Berenberg
    Colgate-Palmolive price target lowered to $77 from $85 at Berenberg
    11/01/21 Jefferies
    Newell Brands remains a top long idea, says Jefferies
    10/05/21
    Fly Intel: Top five analyst initiations
    X U.S. Steel
    $19.55 /

    +0.96 (+5.16%)

    WAL Western Alliance
    $95.19 /

    -12.19 (-11.35%)

    VFC VF Corp.
    $62.96 /

    -4.365 (-6.48%)

    V Visa
    $228.06 /

    +21.93 (+10.64%)

    TER Teradyne
    $112.15 /

    +0.99 (+0.89%)

    TEAM Atlassian
    $318.89 /

    +27.54 (+9.45%)

    SSNLF Samsung
    $57.75 /

    + (+0.00%)

    RHI Robert Half
    $110.26 /

    -0.89 (-0.80%)

    PODD Insulet
    $230.57 /

    +36.16 (+18.60%)

    MMM 3M
    $163.09 /

    -7.03 (-4.13%)

    MDLZ Mondelez
    $66.42 /

    -1.135 (-1.68%)

    LLY Eli Lilly
    $245.09 /

    +8.3 (+3.51%)

    LH LabCorp
    $270.12 /

    +4.27 (+1.61%)

    KR Kroger
    $43.46 /

    -1.94 (-4.27%)

    HOOD Robinhood
    $12.74 /

    +1.13 (+9.73%)

    HD Home Depot
    $366.45 /

    +9.815 (+2.75%)

    GOOG Alphabet
    $2,666.84 /

    +83.78 (+3.24%)

    FICO Fair Isaac
    $493.32 /

    +65.15 (+15.22%)

    ECVT Ecovyst
    $10.35 /

    +0.965 (+10.28%)

    DGX Quest Diagnostics
    $134.78 /

    -0.41 (-0.30%)

    CVX Chevron
    $130.62 /

    -4.74 (-3.50%)

    CL Colgate-Palmolive
    $83.09 /

    +0.38 (+0.46%)

    CAT Caterpillar
    $201.19 /

    -11.09 (-5.22%)

    BIIB Biogen
    $225.22 /

    +6.35 (+2.90%)

    BAH Booz Allen
    $75.27 /

    -6.74 (-8.22%)

    AFRM Affirm
    $59.71 /

    +8.73 (+17.12%)

    AAPL Apple
    $170.28 /

    +11.13 (+6.99%)

    • 19
      Nov
    • 29
      Jul
    • 03
      Feb
    X U.S. Steel
    $19.55 /

    +0.96 (+5.16%)

    V Visa
    $228.06 /

    +21.93 (+10.64%)

    UNCRY UniCredit
    $7.69 /

    +0.05 (+0.65%)

    SSNLF Samsung
    $57.75 /

    + (+0.00%)

    MMM 3M
    $163.09 /

    -7.03 (-4.13%)

    MDLZ Mondelez
    $66.42 /

    -1.135 (-1.68%)

    LLY Eli Lilly
    $245.09 /

    +8.3 (+3.51%)

    LH LabCorp
    $270.12 /

    +4.27 (+1.61%)

    KR Kroger
    $43.46 /

    -1.94 (-4.27%)

    HOOD Robinhood
    $12.74 /

    +1.13 (+9.73%)

    HD Home Depot
    $366.45 /

    +9.815 (+2.75%)

    GOOG Alphabet
    $2,666.84 /

    +83.78 (+3.24%)

    ECVT Ecovyst
    $10.35 /

    +0.965 (+10.28%)

    DGX Quest Diagnostics
    $134.78 /

    -0.41 (-0.30%)

    CVX Chevron
    $130.62 /

    -4.74 (-3.50%)

    CAT Caterpillar
    $201.19 /

    -11.09 (-5.22%)

    BIIB Biogen
    $225.22 /

    +6.35 (+2.90%)

    BAH Booz Allen
    $75.27 /

    -6.74 (-8.22%)

    AFRM Affirm
    $59.71 /

    +8.73 (+17.12%)

    AAPL Apple
    $170.28 /

    +11.13 (+6.99%)

    VFC VF Corp.
    $62.96 /

    -4.365 (-6.48%)

    V Visa
    $228.06 /

    +21.93 (+10.64%)

    UNCRY UniCredit
    $7.69 /

    +0.05 (+0.65%)

    TER Teradyne
    $112.15 /

    +0.99 (+0.89%)

    TEAM Atlassian
    $318.89 /

    +27.54 (+9.45%)

    SSNLF Samsung
    $57.75 /

    + (+0.00%)

    MMM 3M
    $163.09 /

    -7.03 (-4.13%)

    MDLZ Mondelez
    $66.42 /

    -1.135 (-1.68%)

    LLY Eli Lilly
    $245.09 /

    +8.3 (+3.51%)

    LH LabCorp
    $270.12 /

    +4.27 (+1.61%)

    HOOD Robinhood
    $12.74 /

    +1.13 (+9.73%)

    HD Home Depot
    $366.45 /

    +9.815 (+2.75%)

    GOOG Alphabet
    $2,666.84 /

    +83.78 (+3.24%)

    ECVT Ecovyst
    $10.35 /

    +0.965 (+10.28%)

    DGX Quest Diagnostics
    $134.78 /

    -0.41 (-0.30%)

    CVX Chevron
    $130.62 /

    -4.74 (-3.50%)

    CL Colgate-Palmolive
    $83.09 /

    +0.38 (+0.46%)

    CAT Caterpillar
    $201.19 /

    -11.09 (-5.22%)

    BIIB Biogen
    $225.22 /

    +6.35 (+2.90%)

    BAH Booz Allen
    $75.27 /

    -6.74 (-8.22%)

    AFRM Affirm
    $59.71 /

    +8.73 (+17.12%)

    AAPL Apple
    $170.28 /

    +11.13 (+6.99%)

    X U.S. Steel
    $19.55 /

    +0.96 (+5.16%)

    VFC VF Corp.
    $62.96 /

    -4.365 (-6.48%)

    V Visa
    $228.06 /

    +21.93 (+10.64%)

    TER Teradyne
    $112.15 /

    +0.99 (+0.89%)

    TEAM Atlassian
    $318.89 /

    +27.54 (+9.45%)

    MMM 3M
    $163.09 /

    -7.03 (-4.13%)

    MDLZ Mondelez
    $66.42 /

    -1.135 (-1.68%)

    LLY Eli Lilly
    $245.09 /

    +8.3 (+3.51%)

    LH LabCorp
    $270.12 /

    +4.27 (+1.61%)

    KR Kroger
    $43.46 /

    -1.94 (-4.27%)

    HOOD Robinhood
    $12.74 /

    +1.13 (+9.73%)

    HD Home Depot
    $366.45 /

    +9.815 (+2.75%)

    GOOGL Alphabet Class A
    $2,666.17 /

    +81.3 (+3.15%)

    ECVT Ecovyst
    $10.35 /

    +0.965 (+10.28%)

    CVX Chevron
    $130.62 /

    -4.74 (-3.50%)

    CL Colgate-Palmolive
    $83.09 /

    +0.38 (+0.46%)

    CAT Caterpillar
    $201.19 /

    -11.09 (-5.22%)

    BIIB Biogen
    $225.22 /

    +6.35 (+2.90%)

    AFRM Affirm
    $59.71 /

    +8.73 (+17.12%)

    AAPL Apple
    $170.28 /

    +11.13 (+6.99%)

    AAPL Apple
    $170.28 /

    +11.13 (+6.99%)

    Hot Stocks
    Penn National says theScore 'hard at work' preparing for Ontario market opening » 16:25
    01/28/22
    01/28
    16:25
    01/28/22
    16:25
    PENN

    Penn National

    $44.22 /

    +1.86 (+4.39%)

    Penn National Gaming…

    Penn National Gaming issued statements from President and CEO Jay Snowden and theScore CEO John Levy after the Ontario government's announcement that the Province will officially open the market for sports betting and iGaming to private operators on April 4, 2022. "Our team at theScore has been hard at work preparing for the Ontario market opening, which presents a significant business opportunity," said Jay Snowden, President and CEO of Penn National. "As Canada's preeminent digital sports media brand, theScore is uniquely positioned to capitalize on the introduction of the open and regulated internet gaming market in Ontario, its home territory. Launching theScore Bet in Ontario will mark an exciting expansion of our online gaming business into a major new market where we already have an established mobile sports media product in theScore app and a wide base of loyal users. Today's news is very exciting, and I would like to recognize and congratulate the government of Ontario and the AGCO and iGaming Ontario for their dedication to creating a modern open and regulated sports betting and iGaming market." "We commend the Ontario government for their tireless efforts throughout this process and are thrilled to now have a confirmed launch date," said John Levy, CEO, theScore. "The AGCO and iGaming Ontario have been thoughtful and collaborative in their approach to creating and managing this new industry, and the result is a soon-to-be-launched framework that will bring widespread benefits to Ontarians and establish Ontario as one of the biggest and most important regulated gaming markets in North America. We will be ready to launch theScore Bet in Ontario on April 4 and could not be more excited to finally offer our best-in-class mobile sports betting and iGaming experience to customers in our home province." Prior to offering sports betting and iGaming services in Ontario, theScore Bet must satisfy all regulatory requirements imposed by the AGCO and enter into a commercial agreement with iGaming Ontario. theScore Bet previously announced that it received Gaming Labs International certification for Ontario, evidencing gaming platform compliance with the Registrar's Standards for Internet Gaming which satisfied a key pre-launch requirement.

    ShowHide Related Items >><<
    PENN Penn National
    $44.22 /

    +1.86 (+4.39%)

    PENN Penn National
    $44.22 /

    +1.86 (+4.39%)

    01/26/22 Macquarie
    Penn National upgraded to Outperform from Neutral at Macquarie
    01/26/22 Macquarie
    Penn National upgraded to Outperform from Neutral at Macquarie
    01/21/22 Jefferies
    Penn National price target lowered to $49 from $62 at Jefferies
    01/21/22 Needham
    Penn National price target lowered to $76 from $115 at Needham
    PENN Penn National
    $44.22 /

    +1.86 (+4.39%)

    PENN Penn National
    $44.22 /

    +1.86 (+4.39%)

    PENN Penn National
    $44.22 /

    +1.86 (+4.39%)

    PENN Penn National
    $44.22 /

    +1.86 (+4.39%)

    Technical Analysis
    NASDAQ market internals summary » 16:23
    01/28/22
    01/28
    16:23
    01/28/22
    16:23
    $NSD

    NASDAQ Market Internals

    /

    +

    Volume was above average…

    Volume was above average for this time of day. Breadth was mixed with issues and volume bullish while new highs to new lows were bearish (negative divergence). Advancing Issues: 3167 / Declining Issues: 1664 -- for a ratio of 1.9 to 1. Advancing Volume: 3,895,189,000 / Declining Volume: 924,923,000 -- for a ratio of 4.2 to 1. New 52-Week Highs: 21 / New 52-Week Lows: 1158.

    ShowHide Related Items >><<
    $NSD NASDAQ Market Internals
    /

    +

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.